Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.
Published July 5, 2017 · Recall initiated: May 1, 2017
Summary
FDA records drug Class II recall D-0929-2017, published July 5, 2017 and initiated May 1, 2017. Recalling firm: Allergan Sales, LLC; Status: Terminated; Reported quantity: 648 units; Lot: Lot: 93802, EXP NOV 2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Allergan Sales, LLC
- Distributor
- Nationwide in the US
- Lot
- Lot: 93802, EXP NOV 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKeller Funnel 2, REF: HA-001, STERILEEO, Rx Only,May 8, 2024
- FDACombigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mLNovember 22, 2017
- FDALumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC#November 22, 2017
- FDABuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508July 5, 2017
- FDAAva's brand Organic Cashews Roasted & Salted 8 oz. tubs, UPC 8-10111-01035-1July 5, 2017
- FDALumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDCApril 19, 2017
Questions about this recall
Was Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04. recalled?
Yes. FDA published recall D-0929-2017 on July 5, 2017. Reported hazard: Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
What should I do if I have this product?
Voluntary: Firm initiated · Letter